{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:01:26Z","timestamp":1777471286400,"version":"3.51.4"},"reference-count":71,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB\/TRR57"],"award-info":[{"award-number":["SFB\/TRR57"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHI1170\/2-1"],"award-info":[{"award-number":["SCHI1170\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1382"],"award-info":[{"award-number":["CRC1382"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009398","name":"Medizinische Fakult\u00e4t, RWTH Aachen University","doi-asserted-by":"publisher","award":["O3-1"],"award-info":[{"award-number":["O3-1"]}],"id":[{"id":"10.13039\/501100009398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["HEPATO-METABO-PATH"],"award-info":[{"award-number":["HEPATO-METABO-PATH"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>CD62L (L-Selectin) dependent lymphocyte infiltration is known to induce inflammatory bowel disease (IBD), while its function in the liver, especially in non-alcoholic steatohepatitis (NASH), remains unclear. We here investigated the functional role of CD62L in NASH in humans as well as in two mouse models of steatohepatitis. Hepatic expression of a soluble form of CD62L (sCD62L) was measured in patients with steatosis and NASH. Furthermore, CD62L\u2212\/\u2212 mice were fed with a methionine and choline deficient (MCD) diet for 4 weeks or with a high fat diet (HFD) for 24 weeks. Patients with NASH displayed increased serum levels of sCD62L. Hepatic CD62L expression was higher in patients with steatosis and increased dramatically in NASH patients. Interestingly, compared to wild type (WT) mice, MCD and HFD-treated CD62L\u2212\/\u2212 mice were protected from diet-induced steatohepatitis. This was reflected by less fat accumulation in hepatocytes and a dampened manifestation of the metabolic syndrome with an improved insulin resistance and decreased cholesterol and triglyceride levels. Consistent with ameliorated disease, CD62L\u2212\/\u2212 animals exhibited an enhanced hepatic infiltration of Treg cells and a strong activation of an anti-oxidative stress response. Those changes finally resulted in less fibrosis in CD62L\u2212\/\u2212 mice. Additionally, this effect could be reproduced in a therapeutic setting by administrating an anti-CD62L blocking antibody. CD62L expression in humans and mice correlates with disease activity of steatohepatitis. CD62L knockout and anti-CD62L-treated mice are protected from diet-induced steatohepatitis suggesting that CD62L is a promising target for therapeutic interventions in NASH.<\/jats:p>","DOI":"10.3390\/cells9051106","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T13:23:45Z","timestamp":1588166625000},"page":"1106","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["L-Selectin\/CD62L Is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-1239","authenticated-orcid":false,"given":"Hannah K.","family":"Drescher","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, University Hospital, RWTH Aachen, 52074 Aachen, Germany"},{"name":"Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Schippers","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital, RWTH Aachen, 52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2471-7551","authenticated-orcid":false,"given":"Stefanie","family":"Rosenhain","sequence":"additional","affiliation":[{"name":"Institute for Experimental Molecular Imaging, University Hospital, RWTH Aachen University, 52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Gremse","sequence":"additional","affiliation":[{"name":"Institute for Experimental Molecular Imaging, University Hospital, RWTH Aachen University, 52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8942-6048","authenticated-orcid":false,"given":"Laura","family":"Bongiovanni","sequence":"additional","affiliation":[{"name":"Dutch Molecular Pathology Centre, Department of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, 3508 Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"de Bruin","sequence":"additional","affiliation":[{"name":"Dutch Molecular Pathology Centre, Department of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, 3508 Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreepradha","family":"Eswaran","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital, RWTH Aachen, 52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchira U.","family":"Gallage","sequence":"additional","affiliation":[{"name":"Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Pfister","sequence":"additional","affiliation":[{"name":"Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Szydlowska","sequence":"additional","affiliation":[{"name":"Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Heikenwalder","sequence":"additional","affiliation":[{"name":"Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Weiskirchen","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), University Hospital, RWTH Aachen University, 52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital, RWTH Aachen, 52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital, RWTH Aachen, 52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0931","authenticated-orcid":false,"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), University Hospital, RWTH Aachen University, 52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela C.","family":"Kroy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital, RWTH Aachen, 52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_4","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Cheung","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/SLA.0b013e31826b4b7e","article-title":"Liver transplantation for nonalcoholic steatohepatitis: The new epidemic","volume":"256","author":"Agopian","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Conway, B.N., Han, X., Munro, H.M., Gross, A.L., Shu, X.O., Hargreaves, M.K., Zhen, W., Powers, A.C., and Blot, W.J. (2018). The obesity epidemic and rising diabetes incidence in a low-income racially diverse southern US cohort. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190993"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","article-title":"GI epidemiology: Nonalcoholic fatty liver disease","volume":"25","author":"Angulo","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: From steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MOL.0b013e3282ff5e55","article-title":"Hepatic triglyceride synthesis and nonalcoholic fatty liver disease","volume":"19","author":"Choi","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/bmb\/ldw031","article-title":"Non-alcoholic fatty liver disease in 2016","volume":"119","author":"Townsend","year":"2016","journal-title":"Br. Med. Bull."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial","volume":"385","author":"Loomba","year":"2015","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cld.2009.07.006","article-title":"Lifestyle modification as the primary treatment of NASH","volume":"13","year":"2009","journal-title":"Clin. Liver. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/labinvest.3780164","article-title":"VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice","volume":"80","author":"Soriano","year":"2000","journal-title":"Lab. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3832::AID-IMMU3832>3.0.CO;2-J","article-title":"L-selectin and beta7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes","volume":"28","author":"Wagner","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.14310\/horm.2002.1340","article-title":"Intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in children. Do they play a role in the progression of atherosclerosis?","volume":"11","author":"Fotis","year":"2012","journal-title":"Hormones (Athens)"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1083\/jcb.119.1.229","article-title":"Soluble L-selectin is present in human plasma at high levels and retains functional activity","volume":"119","author":"Schleiffenbaum","year":"1992","journal-title":"J. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/1074-7613(94)90076-0","article-title":"Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice","volume":"1","author":"Ord","year":"1994","journal-title":"Immunity"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejcb.2011.02.007","article-title":"L-selectin\u2014A dynamic regulator of leukocyte migration","volume":"91","author":"Wedepohl","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.biocel.2012.12.023","article-title":"Signals regulating L-selectin-dependent leucocyte adhesion and transmigration","volume":"45","author":"Ivetic","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","article-title":"L-selectin: A Major Regulator of Leukocyte Adhesion, Migration and Signaling","volume":"10","author":"Ivetic","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1038\/ncomms15196","article-title":"L-selectin mechanochemistry restricts neutrophil priming in vivo","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"E1461","DOI":"10.1073\/pnas.1417100112","article-title":"L-selectin shedding is activated specifically within transmigrating pseudopods of monocytes to regulate cell polarity in vitro","volume":"112","author":"Rzeniewicz","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.4049\/jimmunol.158.9.4365","article-title":"L-selectin shedding does not regulate human neutrophil attachment, rolling, or transmigration across human vascular endothelium in vitro","volume":"158","author":"Allport","year":"1997","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V82.1.182.bloodjournal821182","article-title":"L-selectin mediates neutrophil rolling in inflamed venules through sialyl LewisX-dependent and -independent recognition pathways","volume":"82","author":"Chambers","year":"1993","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1582-4934.2005.tb00354.x","article-title":"L-selectin: Mechanisms and physiological significance of ectodomain cleavage","volume":"9","author":"Smalley","year":"2005","journal-title":"J. Cell Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1074\/jbc.M609994200","article-title":"Mechanical shedding of L-selectin from the neutrophil surface during rolling on sialyl Lewis x under flow","volume":"282","author":"Lee","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.193.7.863","article-title":"L-selectin shedding regulates leukocyte recruitment","volume":"193","author":"Thomas","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Yang, S., Liu, F., Wang, Q.J., Rosenberg, S.A., and Morgan, R.A. (2011). The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022560"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2249.2000.01082.x","article-title":"Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE)","volume":"119","author":"Font","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"F143","DOI":"10.1136\/fn.78.2.F143","article-title":"Soluble L-selectin concentration in bronchoalveolar lavage fluid obtained from infants who develop chronic lung disease of prematurity","volume":"78","author":"Kotecha","year":"1998","journal-title":"Arch. Dis. Child Fetal. Neonatal. Ed."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/jsre.2000.5954","article-title":"L-Selectin and chemokine response after liver ischemia and reperfusion","volume":"93","author":"McDuffie","year":"2000","journal-title":"J. Surg. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.cgh.2018.12.040","article-title":"Shorter disease duration is associated with higher rates of response to Vedolizumab in patients with Crohn\u2019s disease but not ulcerative colitis","volume":"17","author":"Faleck","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7150\/thno.13624","article-title":"Imalytics Preclinical: Interactive analysis of biomedical volume data","volume":"6","author":"Gremse","year":"2016","journal-title":"Theranostics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2559.2006.02416.x","article-title":"Histological assessment of non-alcoholic fatty liver disease","volume":"49","author":"Hubscher","year":"2006","journal-title":"Histopathology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2214\/AJR.11.6729","article-title":"MRI steatosis grading: Development and initial validation of a color mapping system","volume":"198","author":"Qayyum","year":"2012","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"20704","DOI":"10.3390\/ijms141020704","article-title":"Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)","volume":"14","author":"Takaki","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/10715762.2013.837577","article-title":"Involvement of free radicals and oxidative stress in NAFLD\/NASH","volume":"47","author":"Sumida","year":"2013","journal-title":"Free Radic. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/rheumatology\/34.9.814","article-title":"Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis","volume":"34","author":"Blann","year":"1995","journal-title":"Br. J. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/clin.1993.1098","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"68","author":"Machold","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.4049\/jimmunol.154.6.3015","article-title":"Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patients","volume":"154","author":"Vinas","year":"1995","journal-title":"J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.1780370311","article-title":"Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited","volume":"37","author":"Belmont","year":"1994","journal-title":"Arthritis Rheum."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ijo.2017.102","article-title":"Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease","volume":"41","author":"Lefere","year":"2017","journal-title":"Int. J. Obes. (Lond.)"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"G425","DOI":"10.1152\/ajpgi.00050.2011","article-title":"Role of integrins in fibrosing liver diseases","volume":"301","author":"Patsenker","year":"2011","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jlb.66.3.411","article-title":"Neutrophil activation in sickle cell disease","volume":"66","author":"Lard","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.4049\/jimmunol.155.3.1502","article-title":"L-selectin (CD62L) cross-linking signals neutrophil adhesive functions via the Mac-1 (CD11b\/CD18) beta 2-integrin","volume":"155","author":"Simon","year":"1995","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/oby.2009.113","article-title":"Neutrophil activation in morbid obesity, chronic activation of acute inflammation","volume":"17","author":"Nijhuis","year":"2009","journal-title":"Obesity"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrgastro.2017.138","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1136\/gutjnl-2016-312439","article-title":"Blockade of alphaEbeta7 integrin suppresses accumulation of CD8(+) and Th9 lymphocytes from patients with IBD in the inflamed gut in vivo","volume":"66","author":"Zundler","year":"2017","journal-title":"Gut"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","article-title":"Natural regulatory T cells: Mechanisms of suppression","volume":"13","author":"Miyara","year":"2007","journal-title":"Trends Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"15142","DOI":"10.1128\/JVI.79.24.15142-15150.2005","article-title":"Blockade of neutrophil elastase attenuates severe liver injury in hepatitis B transgenic mice","volume":"79","author":"Takai","year":"2005","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s10620-009-0969-z","article-title":"Reduction in neutrophil count during hepatitis C treatment: Drug toxicity or predictor of good response?","volume":"55","author":"Day","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Rensen, S.S., Bieghs, V., Xanthoulea, S., Arfianti, E., Bakker, J.A., Shiri-Sverdlov, R., Hofker, M.H., Greve, J.W., and Buurman, W.A. (2012). Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052411"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1172\/JCI57990","article-title":"A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1","volume":"122","author":"Pillay","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.yexmp.2017.05.011","article-title":"Augmenter of liver regeneration (ALR) exhibits a dual signaling impact on hepatic acute-phase response","volume":"102","author":"Dayoub","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"ref_63","first-page":"481","article-title":"Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3","volume":"142","author":"Steinhoff","year":"1993","journal-title":"Am. J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/dc17-1318","article-title":"Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis","volume":"41","author":"Apostolopoulou","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2015.12.014","article-title":"Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development","volume":"91","author":"Ramadori","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3484107","DOI":"10.1155\/2018\/3484107","article-title":"Development of NASH in Obese Mice is Confounded by Adipose Tissue Increase in Inflammatory NOV and Oxidative Stress","volume":"2018","author":"Sacerdoti","year":"2018","journal-title":"Int. J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbrc.2004.12.106","article-title":"Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression","volume":"327","author":"Choi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/hep.30227","article-title":"Incomplete differentiation of engrafted bone marrow endothelial progenitor cells initiates hepatic fibrosis in the rat","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/liv.12203","article-title":"Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet","volume":"33","author":"Ibusuki","year":"2013","journal-title":"Liver Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1478-3231.2011.02639.x","article-title":"Neutrophil to lymphocyte ratio: A new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"32","author":"Alkhouri","year":"2012","journal-title":"Liver Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/hep.29276","article-title":"Loss of L-selectin-guided CD8(+), but not CD4(+), cells protects against ischemia reperfusion injury in a steatotic liver","volume":"66","author":"Kolachala","year":"2017","journal-title":"Hepatology"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/5\/1106\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:09:26Z","timestamp":1760364566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/5\/1106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":71,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["cells9051106"],"URL":"https:\/\/doi.org\/10.3390\/cells9051106","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]}}}